Skip to main content
Log in

Inflammopharmacology

Experimental and Therapeutic Studies

Publishing model:

Overview

Inflammopharmacology is a comprehensive resource on all aspects of inflammation and its pharmacological control, emphasizing pain therapy.

  • Compares different inflammatory states and their causes.
  • Examines the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions.
  • Offers in-depth coverage of Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation, and Novel Drugs, Natural Products and Nutraceuticals.
  • Places particular emphasis on methods of measurement of clinical response effects of new agents and adverse effects from anti-rheumatic drugs.
  • Focuses on the safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics.

This is a transformative journal, you may have access to funding.

Editor-in-Chief
  • Kim D. Rainsford
Deputy Editor
  • Phillip Berry
Impact factor
5.8 (2022)
5 year impact factor
5.4 (2022)
Submission to first decision (median)
3 days
Downloads
568,012 (2023)

Latest articles

Journal updates

Journal information

Electronic ISSN
1568-5608
Print ISSN
0925-4692
Abstracted and indexed in
  1. BFI List
  2. BIOSIS
  3. Baidu
  4. Biological Abstracts
  5. CLOCKSS
  6. CNKI
  7. CNPIEC
  8. Chemical Abstracts Service (CAS)
  9. Dimensions
  10. EBSCO
  11. EMBASE
  12. Google Scholar
  13. Japanese Science and Technology Agency (JST)
  14. Medline
  15. Meta
  16. Naver
  17. OCLC WorldCat Discovery Service
  18. Pathway Studio
  19. Portico
  20. ProQuest
  21. Reaxys
  22. SCImago
  23. SCOPUS
  24. Science Citation Index Expanded (SCIE)
  25. TD Net Discovery Service
  26. UGC-CARE List (India)
  27. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG

Navigation